Google Ventures President and CEO Bill Maris highlights the eight life sciences technologies he thinks are the most game-changing - including CRISPR, artificial intelligence and understanding the microbiome.
Stem cell clinics proliferating - but academics still view the work going on at these for-profit centers as quackery. Where, and why, is this market growing?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The same genes in stem cells and cancer cells are being expressed. OncoCyte is using this knowledge to develop a genetic diagnostic test.
Biotech company AmnioChor is bringing new life to perinatal stem cell technology and an alternative to the cord blood banking industry. Currently, parents have an option to allow cord blood to be stored in a public bank, which could be used for research or unrelated transplants. Alternatively, they can pay to have cells stored in […]
Biotechs may be flush with cash, thanks to the ol’ bullish IPO market and an uptick in venture funding. But startups remain on the lookout for alternative funding models – with crowdsourcing front and center. This makes British biotech startup Cell Therapy particularly interesting, it just raised £689,246 – or a bit over $1 million – to launch a stem cell therapy […]
Scientists are now creating primordial germ cells (precursors to egg and sperm) with human stem cells – and even skin cells. This new work, published in Cell today, takes us beyond what was previously just done using stem cells. One of the first events in the early development of both mice and men is the creation of primordial […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A UCSF spinout is growing neuronal stem cells to transplant into the brain, for potential use in treating epilepsy, spinal cord injury, Parkinson’s and Alzheimer’s disease – and investors are listening. Because one thing that differentiates Neurona Therapeutics is that its stem cells turn exclusively into interneuron cells – which are less likely to be tumorigenic than other IPS cells. […]
Fresh off its MassChallenge win, MIT spinoff SQZBiotech is taking its tech to new heights. Namely, it’s partnered with NASA and will be studying its “cell-squeezing” process at the International Space Station, learning how to better insert transformative materials into cells in a microgravity environment. The startup has developed a slick, vector-free method of introducing material into […]
New York regenerative medicine startup EpiBone‘s tagline is apt: “Grow your own bone.” It uses a patient’s own stem cells to create transplantable, highly personalized bone grafts, going after a 900,000-strong market of patients that need some variety of bone graft to treat, say, severe bone trauma, growth defects or genetic disorders. The company is showcased as one […]